Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00229827
Other study ID # 05-092
Secondary ID
Status Terminated
Phase N/A
First received September 13, 2005
Last updated March 14, 2012
Start date May 2005
Est. completion date August 2007

Study information

Verified date May 2007
Source Children's Healthcare of Atlanta
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine the optimal timing for repair of left-to-right shunt lesions such as ventricular septal defects and atrioventricular canals.


Description:

In the past, children with left-to-right shunt lesions such as ventricular septal defects and atrioventricular canal defects were palliated with a pulmonary artery band. This prevented injury to the pulmonary vasculature while the child grew to a size where complete repair could be undertaken. With the improvements in surgical technique and critical care, there is a push to do a primary complete repair for these defects at younger and younger ages. These operations should be delayed as long as possible to allow for growth but not so long that there is unnecessary heart failure and medication requirements. The primary aim is to determine the optimal timing for repair of left-to-right shunt lesions such as ventricular septal defects and atrioventricular canals. The secondary aim is to define the criteria for failing medical anti-congestive heart failure therapy. This study will be conducted through a retrospective chart review.


Recruitment information / eligibility

Status Terminated
Enrollment 200
Est. completion date August 2007
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients in the congenital surgery database

- Patients who have undergone repair of ventricular septal defects

- Patients who have undergone repair of atrioventricular canal defects

Study Design

Time Perspective: Retrospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Children's Healthcare of Atlanta at Egleston Atlanta Georgia

Sponsors (1)

Lead Sponsor Collaborator
Children's Healthcare of Atlanta

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Active, not recruiting NCT00647387 - Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder - Post Approval Study N/A
Completed NCT00890799 - Transcatheter Closure Versus Surgery of Perimembranous Ventricular Septal Defects N/A
Completed NCT02552485 - Evaluation of Latent Pulmonary Arterial Hypertension in Congenital Shunt Lesions N/A